Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Ovarian Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thymus Neoplasms 1Shoulder Disease 1Neuroblastoma 1Neoplasms 1Neoplasm Metastasis 1Mesothelioma 1Margins of Excision 1Lung Neoplasms 1Kidney Neoplasms 1Hernia, Hiatal 1Gastroesophageal Reflux 1Esophageal Neoplasms 1Esophageal Diseases 1Esophageal Achalasia 1Craniopharyngioma 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Hepatocellular 1Breast Cancer Female 1Adenocarcinoma 1

Interventions

Carboplatin 345Cisplatin 240Paclitaxel 208Radiotherapy 206Pemetrexed 190Docetaxel 170Gemcitabine 158pembrolizumab 146Erlotinib Hydrochloride 111Magnetic Resonance Spectroscopy 101Etoposide 98Bevacizumab 96Specimen Handling 84Nivolumab 77durvalumab 73Radiosurgery 73Blood Specimen Collection 65Drug Therapy 61osimertinib 56Vinorelbine 54Gefitinib 50Surveys and Questionnaires 48atezolizumab 44Biopsy 43Irinotecan 42Radiation 41Topotecan 39Standard of Care 38Cyclophosphamide 38Surgical Procedures, Operative 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Tumor Burden × Clear all
NCT06996249 2026-03-03

DuTOC

Dutch Society of Physicians for Pulmonology and Tuberculosis

Recruiting
12,000 enrolled
Other solid neoplasmThoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Mesothelioma, Thymus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡